Why Actos Lawsuits May Top 10,000 Nationwide
The number of filed Actos (pioglitazone) lawsuits is on pace to pass the 10,000 mark, according to some legal analysts. The rise in filings is attributed to the dramatic findings of a few key surveys.
The manufacturer of Actos recently announced the mid-period findings of its ten-year review of the drug. The scientists’ verdict was that patients who took Actos for longer than one-year experienced a forty percent higher probability of developing bladder cancer. Additionally, the U.S. Food and Drug Administration (FDA) concluded that the possibility for congestive heart failure was sufficiently high to justify a black-box warning.
The reason that Actos filings are trending upwards isn’t simply because the findings came to light. It’s that these findings came to light years after Actos was first released onto the market in 1999 and before the drug manufacturer was sufficiently warning the public and health care providers about the risk of harm.
Want to know whether filing an Actos lawsuit is right for you or your family? Talk to the professionals at Fears Nachawati today. With years of experience and dedicated expertise, we know how to advise you properly. For your free consultation, call us at 1.866.545.8364 or email firstname.lastname@example.org. We’re ready to fight for your rights.